TINZAPARIN Side Effects

6434650-8 | Anaemia, Bone Marrow Failure, Haematuria, Thrombocytopenia
on Oct 28, 2009 Male patient from UNITED STATES , 46 years of age, weighting 124.0 lb, was treated with Tinzaparin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, bone marrow failure, haematuria, thrombocytopenia. Tinzaparin dosage: . Patient was hospitalized.

6432220-9 | Deep Vein Thrombosis
Patient was taking Tinzaparin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Oct 27, 2009 from IRELAND Additional patient health information: Female patient , 39 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Tinzaparin dosage: 175 Iu/kg. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6415362-3 | Deep Vein Thrombosis, Metastatic Neoplasm, Pulmonary Embolism
Adverse event was reported on Oct 13, 2009 by a Female patient taking Tinzaparin (View Usage) (Dosage: ) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: IRELAND , 39 years of age, After Tinzaparin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), metastatic neoplasm, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

5951636-8 | Osteopenia, Spinal Compression Fracture
on Oct 29, 2008 Female patient from UNITED KINGDOM , 32 years of age, was diagnosed with thrombosis prophylaxis and was treated with Tinzaparin (View Usage). Patient experienced the following unwanted or unexpected effects: osteopenia, spinal compression fracture. Tinzaparin dosage: .


5951635-6 | Osteopenia, Spinal Compression Fracture
on Oct 29, 2008 Female patient from UNITED KINGDOM , 42 years of age, was diagnosed with thrombosis prophylaxis, systemic lupus erythematosus and was treated with Tinzaparin (View Usage). Patient had the following side effects: osteopenia, spinal compression fracture. Tinzaparin dosage: 7000 - 9000 Iu. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ).

5001623-1 | Candidiasis, Haematocrit Decreased, Haemoglobin Decreased, Hypoglycaemia, Platelet Count Decreased, Pyrexia, Vision Blurred, Weight Decreased, White Blood Cell Count Decreased
Patient was taking Tinzaparin (View Usage). After Tinzaparin was administered, patient had the following side effects: candidiasis, haematocrit decreased, haemoglobin decreased, hypoglycaemia, platelet count decreased, pyrexia, vision blurred, weight decreased, white blood cell count decreased on May 11, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 149.9 lb, was diagnosed with glioblastoma multiforme, thrombosis prophylaxis and. Tinzaparin dosage: 4500iu Qd Sc. During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), TEMODAR (View Temodar Review and Temodar Label ). Patient was hospitalized.